United States Biotechnology & Medical Research

Lumos Pharma Inc (LUMO)

Track

Ticker: LUMO Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Lumos Pharma Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Planned sale 6 Aug 2024
Value US$2,801,689.85 | Price 35.72 | Shares 97,001 (-46.3%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2024-08-06 2024-08-06 PlS Planned sale
McKew John C.

Chief Scientific Officer

Officer
97,001 -46.3%
35.72
US$2,801,690 		97,001 -46.3% 35.72 US$2,801,690
2024-04-03 2024-04-03 PlS Planned sale
McKew John C.

Chief Scientific Officer

Officer
99,174 -32.6%
360.59
US$3,150,077 		99,174 -32.6% 360.59 US$3,150,077
2024-02-07 2024-02-06 PlS Planned sale
McKew John C.

Chief Scientific Officer

Officer
88,786 -25.8%
499.40
US$4,635,871 		88,786 -25.8% 499.40 US$4,635,871
2024-02-06 2024-02-06 PrS Proposed sale
McKew John C.

Officer

Officer
438
3.10
US$1,357 		438 3.10 US$1,357
2023-08-03 2023-08-02 PlS Planned sale
McKew John C.

Chief Scientific Officer

Officer
3,407 -15.4%
3.21
US$10,919 		3,407 -15.4% 3.21 US$10,919
2023-08-02 2023-08-02 PrS Proposed sale
McKew John C.

Officer

Officer
3,407
3.28
US$11,175 		3,407 3.28 US$11,175
2023-04-04 2023-04-04 PlS Planned sale
McKew John C.

Chief Scientific Officer

Officer
2,214 -8.7%
3.27
US$7,240 		2,214 -8.7% 3.27 US$7,240
2023-02-03 2023-02-02 PlS Planned sale
McKew John C.

Chief Scientific Officer

Officer
439 -1.6%
3.53
US$1,550 		439 -1.6% 3.53 US$1,550
2022-11-18 2022-11-16 B Purchase
2.6
McCracken Joseph S
Non-Executive Director
4,000 +34.1%
5.03
US$20,120 		4,000 +34.1% 5.03 US$20,120
2022-09-23 2022-09-23 B Purchase
4.2
Hawkins Richard J

Chief Executive Officer

Executive Director
208 +4.9%
8.80
US$1,830 		208 +4.9% 8.80 US$1,830
2022-09-23 2022-09-21 B Purchase
4.2
Hawkins Richard J

Chief Executive Officer

Executive Director
2,214 +108.2%
8.84
US$19,572 		2,214 +108.2% 8.84 US$19,572
2022-09-21 2022-09-20 B Purchase
4.2
Hawkins Richard J

Chief Executive Officer

Executive Director
1,506 +278.4%
8.75
US$13,178 		1,506 +278.4% 8.75 US$13,178
2022-09-21 2022-09-19 B Purchase
4.2
Hawkins Richard J

Chief Executive Officer

Executive Director
541 +inf%
8.65
US$4,680 		541 +inf% 8.65 US$4,680
2022-08-26 2022-08-25 B Purchase
2.1
Raffin Thomas A.
Non-Executive Director
1,150 +13.9%
8.46
US$9,729 		1,150 +13.9% 8.46 US$9,729
2022-08-26 2022-08-25 B Purchase
2.6
McCracken Joseph S
Non-Executive Director
3,170 +37.1%
8.60
US$27,262 		3,170 +37.1% 8.60 US$27,262
2022-08-03 2022-08-02 PlS Planned sale
McKew John C.

Chief Scientific Officer

Officer
3,407 -12.2%
8.11
US$27,631 		3,407 -12.2% 8.11 US$27,631
2022-06-07 2022-06-06 PlS Planned sale
McKew John C.

Chief Scientific Officer

Officer
169 -0.6%
7.62
US$1,288 		169 -0.6% 7.62 US$1,288
2022-04-05 2022-04-05 PlS Planned sale
McKew John C.

Chief Scientific Officer

Officer
2,214 -7.0%
8.32
US$18,420 		2,214 -7.0% 8.32 US$18,420
2021-01-08 2021-01-08 S Sale
2.8
Flynn James E
Large shareholder
101,600 -11.5%
22.24
US$2,259,797 		101,600 -11.5% 22.24 US$2,259,797
2021-01-08 2021-01-08 S Sale
2.8
Flynn James E
Large shareholder
3,912 -0.4%
23.57
US$92,194 		3,912 -0.4% 23.57 US$92,194
2021-01-08 2021-01-08 S Sale
2.8
Flynn James E
Large shareholder
1,000 -0.1%
24.11
US$24,108 		1,000 -0.1% 24.11 US$24,108
2021-01-08 2021-01-07 S Sale
2.8
Flynn James E
Large shareholder
4,378 -0.5%
25.05
US$109,665 		4,378 -0.5% 25.05 US$109,665
2021-01-08 2021-01-07 S Sale
2.8
Flynn James E
Large shareholder
11,794 -1.3%
24.35
US$287,157 		11,794 -1.3% 24.35 US$287,157
2021-01-08 2021-01-06 S Sale
2.8
Flynn James E
Large shareholder
931 -0.1%
22.64
US$21,082 		931 -0.1% 22.64 US$21,082
2021-01-08 2021-01-06 S Sale
2.8
Flynn James E
Large shareholder
28,108 -3.0%
22.47
US$631,620 		28,108 -3.0% 22.47 US$631,620
2018-07-12 2018-07-10 S Sale Talarico Ernest III Non-Executive Director
13,806 -30.0%
4.82
US$66,600 		13,806 -30.0% 4.82 US$66,600
2017-11-22 2017-11-21 PlS Planned sale Langren Carl W.

Principal Accounting Officer
2,229 -10.2%
9.05
US$20,172 		2,229 -10.2% 9.05 US$20,172
2017-10-06 2017-10-06 B Purchase Stine Seed Farm, Inc. Large shareholder
780,487 +11.0%
10.25
US$7,999,992 		780,487 +11.0% 10.25 US$7,999,992
2016-12-16 2016-12-14 S Sale Langren Carl W.

Principal Accounting Officer

Officer
3,943 -26.9%
10.85
US$42,782 		3,943 -26.9% 10.85 US$42,782
2016-06-08 2016-06-06 B Purchase Talarico Ernest III Non-Executive Director
4,065 +14.4%
12.32
US$50,081 		4,065 +14.4% 12.32 US$50,081
2016-04-11 2016-04-07 PlS Planned sale Link Charles J. Jr.

Chairman of the Board and CEO

Executive Director
10,000 -3.4%
20.03
US$200,250 		10,000 -3.4% 20.03 US$200,250
2016-03-16 2016-03-15 PlS Planned sale Link Charles J. Jr.

Chairman of the Board and CEO

Executive Director
5,000 -1.7%
18.60
US$93,000 		5,000 -1.7% 18.60 US$93,000
2016-03-16 2016-03-15 PlS Planned sale Link Charles J. Jr.

Chairman of the Board and CEO

Executive Director
20,000 -6.3%
17.68
US$353,600 		20,000 -6.3% 17.68 US$353,600
2016-02-04 2016-02-03 PlS Planned sale Link Charles J. Jr.

Chairman of the Board and CEO

Executive Director
13,500 -4.1%
24.46
US$330,210 		13,500 -4.1% 24.46 US$330,210
2016-02-04 2016-02-03 PlS Planned sale Link Charles J. Jr.

Chairman of the Board and CEO

Executive Director
11,500 -3.4%
23.81
US$273,815 		11,500 -3.4% 23.81 US$273,815
2016-01-06 2016-01-06 PlS Planned sale Link Charles J. Jr.

Chairman of the Board and CEO

Executive Director
7,900 -2.3%
33.06
US$261,174 		7,900 -2.3% 33.06 US$261,174
2016-01-06 2016-01-06 PlS Planned sale Link Charles J. Jr.

Chairman of the Board and CEO

Executive Director
17,100 -4.6%
32.29
US$552,159 		17,100 -4.6% 32.29 US$552,159
2016-01-06 2016-01-05 S Sale HENNEMAN JOHN B III

EVP, Chief Financial Officer

Officer
175 -0.3%
35.74
US$6,254 		175 -0.3% 35.74 US$6,254
2016-01-06 2016-01-05 S Sale Langren Carl W.

Principal Accounting Officer

Officer
500 -3.6%
35.42
US$17,710 		500 -3.6% 35.42 US$17,710
2016-01-06 2016-01-05 S Sale Langren Carl W.

Principal Accounting Officer

Officer
595 -4.1%
34.60
US$20,587 		595 -4.1% 34.60 US$20,587
2016-01-06 2016-01-05 S Sale Vahanian Nicholas N.

President, Chief Medical Offic

Officer
1,000 -1.5%
35.57
US$35,570 		1,000 -1.5% 35.57 US$35,570
2016-01-06 2016-01-05 S Sale Vahanian Nicholas N.

President, Chief Medical Offic

Officer
2,011 -2.9%
34.80
US$69,983 		2,011 -2.9% 34.80 US$69,983
2016-01-06 2016-01-05 S Sale Link Charles J. Jr.

Chairman of the Board and CEO

Executive Director
3,621 -1.0%
35.29
US$127,785 		3,621 -1.0% 35.29 US$127,785
2016-01-06 2016-01-05 S Sale Link Charles J. Jr.

Chairman of the Board and CEO

Executive Director
1,380 -0.4%
34.46
US$47,555 		1,380 -0.4% 34.46 US$47,555
2016-01-06 2016-01-05 S Sale Wiley Brian

VP of Business Development

Officer
1,000 -4.8%
35.20
US$35,200 		1,000 -4.8% 35.20 US$35,200
2016-01-06 2016-01-05 S Sale Wiley Brian

VP of Business Development

Officer
295 -1.4%
34.26
US$10,107 		295 -1.4% 34.26 US$10,107
2015-07-15 2015-07-13 S Sale Saluri Joseph Non-Executive Director
5,000 -23.8%
50.42
US$252,100 		5,000 -23.8% 50.42 US$252,100
2015-06-03 2015-06-01 PlS Planned sale Ramsey William J.

Quality Assurance Officer

Officer
1,000 -3.0%
42.94
US$42,940 		1,000 -3.0% 42.94 US$42,940
2015-06-03 2015-06-01 PlS Planned sale Ramsey William J.

Quality Assurance Officer

Officer
1,500 -4.3%
42.53
US$63,795 		1,500 -4.3% 42.53 US$63,795
2015-04-09 2015-04-07 PlS Planned sale Raffin Thomas A. Non-Executive Director
9,870 -13.6%
55.03
US$543,146 		9,870 -13.6% 55.03 US$543,146
2015-04-09 2015-04-07 PlS Planned sale Raffin Thomas A. Non-Executive Director
10,024 -12.1%
54.32
US$544,504 		10,024 -12.1% 54.32 US$544,504
2015-04-09 2015-04-07 PlS Planned sale Raffin Thomas A. Non-Executive Director
800 -1.0%
53.18
US$42,544 		800 -1.0% 53.18 US$42,544
2015-03-20 2015-03-18 S Sale Langren Carl W.

Principal Accounting Officer

Officer
7,000 -12.3%
53.00
US$371,000 		7,000 -12.3% 53.00 US$371,000
2015-03-20 2015-03-18 S Sale Langren Carl W.

Principal Accounting Officer

Officer
3,429 -100.0%
53.00
US$181,737 		3,429 -100.0% 53.00 US$181,737
2015-03-20 2015-03-18 S Sale Langren Carl W.

Principal Accounting Officer

Officer
3,429 -100.0%
53.00
US$181,737 		3,429 -100.0% 53.00 US$181,737
2015-03-20 2015-03-18 S Sale Langren Carl W.

Principal Accounting Officer

Officer
2,500 -100.0%
53.00
US$132,500 		2,500 -100.0% 53.00 US$132,500
2015-03-19 2015-03-18 S Sale Talarico Ernest III Non-Executive Director
1,000 -3.7%
53.75
US$53,750 		1,000 -3.7% 53.75 US$53,750
2015-03-19 2015-03-17 S Sale Talarico Ernest III Non-Executive Director
19,532 -42.7%
52.89
US$1,033,047 		19,532 -42.7% 52.89 US$1,033,047
2014-10-28 2014-10-24 S Sale LINK GORDON H JR

Chief Financial Officer

Officer
2,500 -14.8%
40.39
US$100,975 		2,500 -14.8% 40.39 US$100,975
2014-02-11 2014-02-07 S Sale Saluri Joseph Non-Executive Director
4,761 -29.9%
38.80
US$184,723 		4,761 -29.9% 38.80 US$184,723
2014-02-11 2014-02-07 S Sale Talarico Ernest III Non-Executive Director
25,000 -48.7%
37.06
US$926,538 		25,000 -48.7% 37.06 US$926,538
2014-01-23 2014-01-21 S Sale Langren Carl W.

Principal Accounting Officer

Officer
3,586 -51.1%
34.81
US$124,833 		3,586 -51.1% 34.81 US$124,833
2014-01-23 2014-01-21 S Sale Langren Carl W.

Principal Accounting Officer

Officer
3,587 -51.1%
34.81
US$124,868 		3,587 -51.1% 34.81 US$124,868
2014-01-17 2014-01-15 S Sale Langren Carl W.

Principal Accounting Officer

Officer
1,414 -16.8%
29.95
US$42,349 		1,414 -16.8% 29.95 US$42,349
2014-01-17 2014-01-15 S Sale Langren Carl W.

Principal Accounting Officer

Officer
1,413 -16.8%
29.95
US$42,319 		1,413 -16.8% 29.95 US$42,319
2014-01-09 2014-01-07 PlS Planned sale LINK GORDON H JR

Chief Financial Officer

Officer
453 -3.1%
22.55
US$10,215 		453 -3.1% 22.55 US$10,215
2014-01-06 2014-01-06 PlS Planned sale Link Charles J. Jr.

Chairman of the Board and CEO

Executive Director
9,000 -1.0%
22.44
US$201,915 		9,000 -1.0% 22.44 US$201,915
2014-01-07 2014-01-03 PlS Planned sale Vahanian Nicholas N.

President, Chief Medical Offic

Officer
4,196 -4.3%
22.19
US$93,113 		4,196 -4.3% 22.19 US$93,113
2014-01-07 2014-01-03 PlS Planned sale Vahanian Nicholas N.

President, Chief Medical Offic

Officer
22,925 -19.7%
22.19
US$508,724 		22,925 -19.7% 22.19 US$508,724
2014-01-07 2014-01-03 PlS Planned sale Vahanian Nicholas N.

President, Chief Medical Offic

Officer
41 -0.0%
22.19
US$910 		41 -0.0% 22.19 US$910
2014-01-06 2014-01-03 PlS Planned sale Ramsey William J.

Quality Assurance Officer

Officer
8,604 -20.6%
22.00
US$189,288 		8,604 -20.6% 22.00 US$189,288
2014-01-06 2014-01-03 PlS Planned sale Link Charles J. Jr.

Chairman of the Board and CEO

Executive Director
11,000 -1.2%
21.97
US$241,626 		11,000 -1.2% 21.97 US$241,626
2013-12-05 2013-12-03 PlS Planned sale LINK GORDON H JR

Chief Financial Officer

Officer
449 -6.5%
20.96
US$9,410 		449 -6.5% 20.96 US$9,410
2013-12-02 2013-12-02 PlS Planned sale Vahanian Nicholas N.

President, Chief Medical Offic

Officer
30,000 -30.3%
22.19
US$665,760 		30,000 -30.3% 22.19 US$665,760
2013-12-02 2013-11-29 PlS Planned sale Vahanian Nicholas N.

President, Chief Medical Offic

Officer
7,500 -7.0%
22.07
US$165,556 		7,500 -7.0% 22.07 US$165,556
Explore more

More insider trading research around Lumos Pharma Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America